Cara Therapeutics to Webcast Presentation at the 16th Annual Needham Healthcare Conference
March 28 2017 - 4:30PM
Cara Therapeutics, Inc. (Nasdaq:CARA), a biotechnology company
focused on developing and commercializing new chemical entities
designed to alleviate pain and pruritus by selectively targeting
peripheral kappa opioid receptors, today announced that Dr. Derek
Chalmers, President and CEO, will present a company overview at the
16th Annual Needham Healthcare Conference on Tuesday, April 4,
2017, at 9:20 a.m. ET in New York City.
A live webcast of the presentation can be accessed under “Events
and Presentations” in the News & Investors section of the
Company’s website at www.CaraTherapeutics.com. An archived webcast
recording will be available on the Cara website for approximately
30 days.
About Cara Therapeutics
Cara Therapeutics is a clinical-stage
biotechnology company focused on developing and commercializing new
chemical entities designed to alleviate pain and pruritus by
selectively targeting peripheral kappa opioid receptors. Cara is
developing a novel and proprietary class of product candidates that
target the body's peripheral nervous system and have demonstrated
initial efficacy in patients with moderate-to-severe pain without
inducing many of the undesirable side effects typically associated
with currently available pain therapeutics.
INVESTOR CONTACT:
Michael Schaffzin
Stern Investor Relations, Inc.
212-362-1200
michael@sternir.com
MEDIA CONTACT:
Annie Starr
6 Degrees
973-415-8838
astarr@6degreespr.com
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From Apr 2024 to May 2024
Cara Therapeutics (NASDAQ:CARA)
Historical Stock Chart
From May 2023 to May 2024